SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-216343
Filing Date
2022-08-10
Accepted
2022-08-09 18:20:19
Documents
16
Period of Report
2022-07-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d388401d8k.htm   iXBRL 8-K 27192
2 EX-99.1 d388401dex991.htm EX-99.1 54136
7 GRAPHIC g388401dsp01a.jpg GRAPHIC 5443
8 GRAPHIC g388401dsp01b.jpg GRAPHIC 7952
  Complete submission text file 0001193125-22-216343.txt   268379

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btmd-20220720.xsd EX-101.SCH 3569
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE btmd-20220720_def.xml EX-101.DEF 13880
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20220720_lab.xml EX-101.LAB 22722
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20220720_pre.xml EX-101.PRE 14708
10 EXTRACTED XBRL INSTANCE DOCUMENT d388401d8k_htm.xml XML 5711
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 221149800
SIC: 2833 Medicinal Chemicals & Botanical Products